Holen Sie sich die Stockscreener-App
7.855
2.15%
0.165
Vorhandelsmarkt:
7.97
0.115
+1.46%
Schlusskurs vom Vortag:
$7.69
Offen:
$7.71
24-Stunden-Volumen:
62,285
Relative Volume:
0.38
Marktkapitalisierung:
$213.15M
Einnahmen:
$56.13M
Nettoeinkommen (Verlust:
$-14.67M
KGV:
-10.61
EPS:
-0.74
Netto-Cashflow:
$-9.13M
1W Leistung:
+0.32%
1M Leistung:
-12.72%
6M Leistung:
+5.44%
1J Leistung:
+40.52%
1-Tages-Spanne:
$7.54
$8.01
1-Wochen-Bereich:
$7.27
$8.155
52-Wochen-Spanne:
$3.535
$9.40
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Vergleichen Sie DERM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.855 | 208.68M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
120.41 | 54.02B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.28 | 45.21B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.53 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.41 | 31.93B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.21 | 20.71B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
| 2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Layoff Tracker: Valneva Terminates 30 Amid Site Closure - BioSpace
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Strategic Wealth LLC Takes $250,000 Position in HCA Healthcare, Inc. $HCA - MarketBeat
VITAS Healthcare (CHE) shares caregiver Stacy Noland's hospice-at-home story in new video - Stock Titan
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation $DERM - MarketBeat
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Head-To-Head Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Journey Medical (NASDAQ:DERM) - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS) - The Globe and Mail
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo! Finance Canada
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Fourteen new option listings on November 12th - MSN
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Is Journey Medical Corporation forming a reversal patternFed Meeting & Low Drawdown Trading Strategies - newser.com
FY2029 EPS Estimates for Journey Medical Boosted by Analyst - Defense World
What valuation multiples suggest for Journey Medical Corporation stockPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
Can Journey Medical Corporation stock deliver sustainable ROEQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
B. Riley Increases Earnings Estimates for Journey Medical - MarketBeat
HC Wainwright Forecasts Weaker Earnings for Journey Medical - MarketBeat
Can Journey Medical Corporation stock attract ESG capital inflowsTrade Exit Summary & Daily Growth Stock Tips - newser.com
Journey Medical Corp. Hits New 52-Week High of $9.40 - Markets Mojo
Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wall Street analysts’ outlook for Journey Medical Corp (DERM) - Setenews
Fortress Biotech, Inc. (NASDAQ:FBIO) Q3 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Journey Medical Corp (DERM) - The Globe and Mail
Journey Medical (NASDAQ:DERM) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Journey Medical price target raised to $16 from $10 at Alliance Global - TipRanks
Buy Rating for Journey Medical Corp Driven by Emrosi’s Market Success and Growth Potential - TipRanks
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Journey Medical Q3 2025 Earnings Call Transcript - MarketBeat
Journey Medical reports Q3 EPS (9c), consensus (4c) - TipRanks
Journey Medical earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: Journey Medical’s Q3 2025 shows revenue jump and strategic growth - Investing.com
Earnings call transcript: Journey Medical Q3 2025 sees revenue growth - Investing.com
Journey Medical Corp SEC 10-Q Report - TradingView
[10-Q] Journey Medical Corp Quarterly Earnings Report | DERM SEC FilingForm 10-Q - Stock Titan
Journey Medical Corporation (DERM) Q3 FY2025 earnings call transcript - Yahoo Finance
Journey Medical Q3 revenue up 21% on increase in Emrosi prescriptions - MarketScreener
[8-K] Journey Medical Corp Reports Material Event | DERM SEC FilingForm 8-K - Stock Titan
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.96%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):